142 related articles for article (PubMed ID: 27143370)
1. [Basic carboxypeptidases of blood: significance for coagulology].
Timofeev АV
Biomed Khim; 2016; 62(2):141-9. PubMed ID: 27143370
[TBL] [Abstract][Full Text] [Related]
2. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Bouma BN; Meijers JC
Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
[TBL] [Abstract][Full Text] [Related]
3. Carboxypeptidase U at the interface between coagulation and fibrinolysis.
Schatteman K; Goossens F; Leurs J; Verkerk R; Scharpé S; Michiels JJ; Hendriks D
Clin Appl Thromb Hemost; 2001 Apr; 7(2):93-101. PubMed ID: 11292199
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
Bouma BN; Marx PF; Mosnier LO; Meijers JC
Thromb Res; 2001 Mar; 101(5):329-54. PubMed ID: 11297751
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic activation of purified human procarboxypeptidase U.
Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF
Clin Chim Acta; 2000 Feb; 292(1-2):25-40. PubMed ID: 10686274
[TBL] [Abstract][Full Text] [Related]
6. TAFI meets the sticky ends.
Booth NA
Thromb Haemost; 2001 Jan; 85(1):1-2. PubMed ID: 11204558
[No Abstract] [Full Text] [Related]
7. Plasma carboxypeptidases as regulators of the plasminogen system.
Redlitz A; Tan AK; Eaton DL; Plow EF
J Clin Invest; 1995 Nov; 96(5):2534-8. PubMed ID: 7593646
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma.
Leurs J; Wissing BM; Nerme V; Schatteman K; Björquist P; Hendriks D
Thromb Haemost; 2003 Feb; 89(2):264-71. PubMed ID: 12574805
[TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen.
Wang W; Hendriks DF; Scharpé SS
J Biol Chem; 1994 Jun; 269(22):15937-44. PubMed ID: 8195249
[TBL] [Abstract][Full Text] [Related]
10. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not.
Sato T; Miwa T; Akatsu H; Matsukawa N; Obata K; Okada N; Campbell W; Okada H
J Immunol; 2000 Jul; 165(2):1053-8. PubMed ID: 10878383
[TBL] [Abstract][Full Text] [Related]
11. Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.
Valnickova Z; Enghild JJ
J Biol Chem; 1998 Oct; 273(42):27220-4. PubMed ID: 9765243
[TBL] [Abstract][Full Text] [Related]
12. [Kinin system, blood coagulation and fibrinolysis in glomerulonephritis].
Alekseev GI; Bobrov LL
Klin Med (Mosk); 1979 Jul; 57(7):72-6. PubMed ID: 480888
[No Abstract] [Full Text] [Related]
13. [Basic (cleaving arginine and lysine residues) metallocarboxypeptidase of mammalian tissue: structure, properties and function].
Vernigora AN; Gengin MT
Ukr Biokhim Zh (1978); 1998; 70(4):16-24. PubMed ID: 9848196
[TBL] [Abstract][Full Text] [Related]
14. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis and the plasma carboxypeptidase.
Nesheim M
Curr Opin Hematol; 1998 Sep; 5(5):309-13. PubMed ID: 9776208
[TBL] [Abstract][Full Text] [Related]
16. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
[TBL] [Abstract][Full Text] [Related]
17. Which carboxypeptidase determines the antifibrinolytic potential?
Gils A
J Thromb Haemost; 2008 May; 6(5):846-7. PubMed ID: 18284599
[No Abstract] [Full Text] [Related]
18. Binding of carboxypeptidase N to fibrinogen and fibrin.
Talens S; Lebbink JH; Malfliet JJ; Demmers JA; Uitte de Willige S; Leebeek FW; Rijken DC
Biochem Biophys Res Commun; 2012 Oct; 427(2):421-5. PubMed ID: 23000409
[TBL] [Abstract][Full Text] [Related]
19. [Arginine and lysine as products of basic carboxypeptidase activity associated with fibrinolysis].
Zhloba AA; Subbotina TF; Lupan DS; Bogova VA; Kusheleva OA
Biomed Khim; 2013; 59(5):570-7. PubMed ID: 24479347
[TBL] [Abstract][Full Text] [Related]
20. Heat stability of carboxypeptidase R of experimental animals.
Komura H; Shimomura Y; Yumoto M; Katsuya H; Okada N; Okada H
Microbiol Immunol; 2002; 46(3):217-23. PubMed ID: 12008932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
